Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
80.84
-0.35 (-0.43%)
Apr 7, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 19 analysts that cover Edwards Lifesciences stock have a consensus rating of "Buy" and an average price target of $96.47, which forecasts a 19.33% increase in the stock price over the next year. The lowest target is $81 and the highest is $110.
Price Target: $96.47 (+19.33%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 7 | 7 | 7 | 7 |
| Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $94 → $92 | Buy | Maintains | $94 → $92 | +13.81% | Apr 6, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $108 → $95 | Strong Buy | Maintains | $108 → $95 | +17.52% | Feb 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $98 → $100 | Buy | Reiterates | $98 → $100 | +23.70% | Feb 11, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $92 → $89 | Hold | Maintains | $92 → $89 | +10.09% | Feb 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $96 → $100 | Buy | Maintains | $96 → $100 | +23.70% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
6.88B
from 6.07B
Increased by 13.39%
Revenue Next Year
7.55B
from 6.88B
Increased by 9.78%
EPS This Year
3.01
from 1.83
Increased by 64.40%
EPS Next Year
3.37
from 3.01
Increased by 11.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.1B | 7.9B | |||
| Avg | 6.9B | 7.6B | |||
| Low | 6.5B | 7.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.8% | 14.7% | |||
| Avg | 13.4% | 9.8% | |||
| Low | 6.8% | 2.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.18 | 3.60 | |||
| Avg | 3.01 | 3.37 | |||
| Low | 2.33 | 2.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 73.2% | 19.5% | |||
| Avg | 64.4% | 12.0% | |||
| Low | 27.3% | -12.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.